Axis Direct has initiated a 'Buy' rating on Navin Fluorine International with a target price of Rs 9,000, projecting a 10% upside. The brokerage cites strong momentum in High-Performance Products (HPP), a robust specialty chemicals pipeline, and significant growth in CDMO services as key catalysts for the firm's earnings expansion through FY28.
Axis Direct Bullish on Navin Fluorine with Rs 9,000 Target
Target Price: Rs 9,000 | Upside: 10% (6-9 Month Horizon)
Reader Takeaway: Strong growth in HPP and CDMO divisions drives optimism, though timely facility commissioning remains crucial for revenue.
What just happened
Axis Direct has issued a 'Buy' recommendation on Navin Fluorine International, setting a target price of Rs 9,000. The brokerage projects a strong financial trajectory for the chemical manufacturer, forecasting net sales to reach Rs 5,862 crore by FY28, with PAT expected to hit Rs 1,369 crore.
Why this matters
The recommendation is anchored in the performance of three core divisions. The High-Performance Products (HPP) segment saw 33% year-on-year growth, bolstered by rising global demand for R32 gas. Meanwhile, the specialty chemicals business grew by 48% and the CDMO division saw an 82% surge, reflecting deeper integration with major global partners.
The backstory
Navin Fluorine has been scaling its operational capabilities significantly. The company is currently executing a 15,000 MTPA R32 expansion scheduled for Q3FY27 and is investing Rs 125 crore in its Phase II cGMP4 facility. These assets are vital for achieving the company's long-term revenue targets and maintaining EBITDA margins in the 30%–33% range.
Risks to watch
Investors should monitor the execution timelines for the upcoming R32 and cGMP4 capacity expansions. Any delays in commissioning these facilities could impact the projected revenue realization and operating leverage expected by the brokerage in the coming quarters.
Context metrics (FY28E)
- Net Sales: Rs 5,862 Cr
- EBITDA: Rs 1,950 Cr
- PAT: Rs 1,369 Cr
- EPS: Rs 267.4